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Abstract
The objective of this work was to examine the effects of magnet distance (and by proxy, field strength) on
nanomagnetic transfection efficiency.
Methods: Non-viral magnetic nanoparticle-based transfection was evaluated using both static and oscillating
magnet arrays.
Results: Fluorescence intensity (firefly luciferase) of transfected H292 cells showed no increase using a 96-well
NdFeB magnet array when the magnets were 5 mm from the cell culture plate or nearer. At 6 mm and higher,
fluorescence intensity decreased systematically.
Conclusion: In all cases, fluorescence intensity was higher when using an oscillating array compared to a static
array. For distances closer than 5 mm, the oscillating system also outperformed Lipofectamine 2000
TM.
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O
ver the last decade, new magnetic technologies
have been developed to improve the uptake and
expression of DNA and siRNA in cells growing
in culture (1, 2). The use of magnetic nanoparticles for
DNA delivery was first exemplified by Mah et al. (3, 4).
In those studies, adeno-associated viral vectors coding for
the green fluorescent protein (GFP) were coupled to
micron-sized magnetic nanoparticles and introduced into
HeLa cell cultures. High field/high gradient NdFeB
magnets were placed beneath the cell culture plate to
concentrate the vectors at a specific location within the
cell culture and this was shown to improve both targeting
and speed of transfection.
Following on from that work, Scherer, Plank and
others developed a non-viral alternative of this technol-
ogy, known as magnetofection, in which DNA was
coupled directly to magnetic nanoparticles via charge
interactions (2, 5). In this technique, particle/DNA
complexes are taken up via endocytosis mechanisms
and, once inside the cell, proton pumps are activated
that rupture the endosome and release the DNA
(6, 7).
More recently, the use of a combination of translational
magnetic forces acting on the particles along the z-axis
and oscillation of the field or magnet arrays in the xy
plane has been shown to improve transfection efficiency
when compared to both cationic lipid complexes and
static magnetofection (811) (Fig. 1). This has recently
been extended to the transport of magnetic-DNA carriers
through viscous gels (12).
In all these cases, the force exerted on the particle is
proportional to both the field strength and field gradient
(13). As such, it is important to understand the effects of
these parameters on transfection efficiency in order to
improve both in vitro nanomagnetic transfection and,
more importantly, to develop the technology for in vivo
targeting and transfection. In order to understand the
relationship between field strength/gradient and transfec-
tion efficiency, we have evaluated luciferase activity, a
proxy of protein production, as a function of magnet
distance in both static and oscillating systems and
compared them to one of the leading cationic lipid
transfection agents, Lipofectamine 2000
TM.
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In order to determine the optimal working distance
between the magnet and the cell culture for the improve-
ment of transfection efficiency in NCI-H292 cells, magnet
arrays were rearranged in the following format: in column
1, magnet discs were positioned 3 mm beneath the cell
surfaceofthe96-wellplate.Following,incolumns3,5,7,9
and 11, the magnet discs were rearranged so that the
distance between the magnet and the cell surface (bottom
of the culture plate) was at 3, 4, 5, 6, 7 and 8 mm
correspondingly (Fig. 2).
This magnet array has been rearranged for the
purposes of the experiment as described earlier, to
gradually increase the distance between the magnet array
Fig. 1. Proposed mechanism of oscillating nanomagnetic transfection (After ref. 17). Plasmid DNA or siRNA is attached to
magnet nanoparticles and incubated with cells in culture (left). An oscillating magnet array below the surface of the cell culture
plate pulls the particle into contact with the cell membrane (i) and drags the particles from side-to-side across the cells (ii),
mechanically stimulating endocytosis (iii). Once the particle/DNA complex is endocytosed, proton sponge effects rupture the
endosome (iv) releasing the DNA (v), which then transcribes the target protein (vi).
Fig. 2. Redcliffe MagScan image of a nanoTherics Ltd. magnet array obtained at 3 mm distance between the scanning probe
and the magnet surface.
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of the wells in column 1 (at 3 mm distance) the highest
magnetic field was obtained, reaching 101 mT.
The same magnet array mapped in Fig. 2 was used in
the next experiment to investigate the magnetofection
levels of NCI-H292 cells when transfected with Chemicell
Polymag nanoparticles at different magnet distances
during 2-h exposure.
Transfections were performed in 96-well tissue culture
plates using 0.1 mg of 0.2 mg/ml pCIKLux DNA/well for
2 h. The 96-well plates were placed above the magnets at a
distance ranging between 3 and 8 mm. The data obtained
were expressed as mean9standard error of mean (SEM)
relative light units (RLU)/milligram protein (N12) for
200 mm/2 Hz oscillation amplitude.
Results from the 2-h transfection of NCI-H292 cells
presented in Fig. 3 show that, regardless of magnet
distance, luciferase activity using the oscillating field
was significantly higher than static magnetofection
(PB0.001). It was also observed that the highest level
of activity was obtained at 3 mm distance between
the magnet and the cell surface, though there was no
statistically significant improvement when compared to 4,
5, 6 and 7 mm distances. At distances below 6 mm, the
oscillating system outperformed Lipofectamine 2000
TM at
both 2- and 6-h transfection durations (PB0.01).
The significant drop-off in luciferase activity between
7 and 8 mm was seen in both the oscillating and static
systems. In Fig. 4, luciferase activity obtained by the
transfection of NCI-H292 cells shown in Fig. 3 was
comparedwith the corresponding magnetic field strength.
This shows that protein production increases with
increasing field strength up to a point. At fields higher
than 40 mT, there does not appear to be a corresponding
increase in luciferase activity. These observations give an
indication of the field parameters required to translate
the technology from multi-well plates to in vivo systems.
At all field strengths (magnet distances) tested, luciferase
expression was higher in the oscillating system compared
to the static magnet array (Fig. 4).
Transfections were performed in 96-well tissue culture
plates using 0.1 mg of 0.2 mg/ml pCIKLux DNA/well
with a 2-h transfection time at 200 mm/2 Hz oscillation
amplitude.
As part of the optimization of the magnetic
nanoparticle-based transfection technique, it is necessary
to understand the effects of magnetic field strength and
distance on transfection efficiency and protein produc-
tion. The effect of the gradually increased distance
between the magnet array and the cell culture revealed
that the highest luciferase expression levels of NCI-H292
cells were achieved at the closest spacing between the
magnet and the cells (3 mm). However, the difference in
luciferase expression was not statistically significant when
compared to 4 and 5 mm distances, providing scope for
potentially transfecting cultured tissue explants with
this technique. These results demonstrate that there is a
plateau effect beyond which transfection efficiency is not
improved.
As the forces generated on the particle/plasmid
complex are in the picoNewton range, effects on cell
membrane integrity will be negligible. The primary
mechanism for uptake is likely to be via increased
endocytosis due to mechanical stimulation, as has
been seen in previous studies of magnetic ion channel
activation (1416). Though this mechanical stimulation
can potentially affect downstream protein production in
mechanoresponsive cells, reporter constructs such as
luciferase and GFP will be dependent on cell entry and
Fig. 3. Luciferase activity in NCI-H292 human lung mucoepidermoid carcinoma cells transfected with pCIKLux luciferase
reporter construct using Chemicell Polymag particles (‘no magnet’, ‘static ﬁeld’ and ‘oscillating ﬁeld’), Lipofectamine (LF2000)
and DNA (control).
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It should be noted here that luciferase activity is
not directly related to the number/percentage of cells
transfected, but rather is a proxy for protein/enzyme
production. The technique was used here to provide a
rapid and quantitative direct comparison between sample
groups under the same experimental conditions at
different magnet distances in order to determine the
effects of field strength and gradient and, by proxy,
magnetic force on protein/enzyme production. It was
observed that the magnefect-nano
TM oscillating field
system showed improved luciferase expression when
compared to both static field and Lipofectamine 2000
TM
(2 and 6 h). Such increases in luciferase activity as well as
increases in transfection efficiency using GFP have been
reported in earlier studies of oscillating magnetic systems
(911). This is important as cationic lipid-mediated
gene delivery, or lipofection, is the most widely used
non-viral in vitro transfection method. These results
provide evidence of threshold effects in nanomagnetic
transfection that could be further investigated and
exploited in the determination of field parameters for
the translation of this technology from in vitro to in vivo
studies.
Methods
Materials and reagents
The eukaryotic expression plasmid pCIKLux carrying a
luciferase reporter gene was complexed with different
Polymag particles (diameter 100 nm) that were
purchased from Christian Plank (OZB composition 
CP.X111.77; OzBiosciences, Marseille, France) and
Chemicell (Berlin, Germany). The pCI/pCIKLux plasmid
DNAwas kindly donated by the UKCystic Fibrosis Gene
Therapy Consortium. NdFeB magnets were purchased
from Magnet Sales (Swindon, UK). Luciferase assay
reagents were purchased from Promega (Southampton,
UK). All cell culture reagents were supplied by Sigma-
Aldrich (Dorset, UK) and Biosera (Sussex, UK).
Magnet arrays
Static and oscillating arrays of NdFeB magnets config-
ured for 96-well plate transfections were supplied by
nanoTherics Ltd. Magnetic fields were mapped using a
Redcliffe Magtronics MagScan 500. For static field
experiments, the cell culture plates were placed directly
above the magnet array and both were transferred into an
incubator for the duration of transfection. For oscillating
field experiments, the cell culture plates were placed
directly above the magnet array holder, mounted onto a
computer-controlled slide assembly (magnefect-nano,
nanoTherics Ltd.). The cell culture plate and magnefect-
nano oscillating system were transferred into an incubator
for the duration of transfection and were interfaced to
control electronics outside the incubator. Oscillating array
experiments were performed at 2 Hz oscillation frequency
and 200 mm amplitude.
Mammalian cell treatment before transfection
Human lung mucoepidermoid carcinoma cells (NCI-
H292) were maintained in RPMI 1640 culture medium
supplemented with 10% fetal calf serum, 100 U/ml
penicillin, 0.1 mg/ml streptomycin, 0.25 mg/ml amphor-
tericin B and 2 mM l-glutamine. Before transfection, cells
were seeded into 96-well tissue culture plates (from Iwaki)
at a density of 210
4 cells per well and incubated at 378C
and 5.0% CO2 for a period of 24 h to allow cells to adhere
to the bottom of the wells.
Transfection conditions: magnet transfection
All transfections were performed in 100 ml of serum-free
(SF) RPMI medium using 0.1 mg of 0.2 mg/ml pCIKLux
DNA and 0.1 ml of Polymag per well. Following
the addition of reagents, the cell culture plates were
transferred to an incubator at 378C, 5% CO2, and placed
above the static and oscillating magnetic fields for 2 h.
At 2-h post-transfection, the medium was replaced with
100 ml of RPMI 1640 supplemented with 10% fetal calf
serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin,
0.25 mg/ml amphortericin B and 2 mM l-glutamine
and the cell culture plates were transferred back into
the incubator for 48 h before analysis. DNA/particle
concentrations were determined from DNA binding
curves. The amount of bound and unbound DNA was
measured using an Eppendorf BioPhotometer.
Transfection conditions: Lipofectamine 2000
TM
NCI-H292 cells were maintained as described above and
seeded into 96-well tissue culture plates. Lipofectamine
2000
TM transfections were performed in SF RPMI
medium using 0.1 mg of 0.2 mg/ml pCIKLux DNA and
0.3 mg of Lipofectamine 2000
TM per well following the
manufacturer’s recommended protocol. Cells transfected
with 0.1 mg of 0.2 mg/ml pCIKLux DNA (DNA only)
and cells exposed to SF medium (medium only) were
Fig. 4. Luciferase activity in NCI-H292 cells transfected
with pCIKLux luciferase reporter construct using Chemicell
Polymag particles (‘static ﬁeld’ and ‘oscillating ﬁeld’).
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medium of all samples was replaced with 100 ml of RPMI
1640 medium supplemented with 10% fetal calf serum,
100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.25 mg/ml
amphortericin B and 2 mM l-glutamine and the cell
culture plates were transferred back into the incubator for
48 h before analysis.
Luciferase assay
At 48-h post-transfection, the medium was removed from
all samples and cells were lysed by the addition of 30 ml/
well of cell reporter lysis buffer (Promega). Samples were
assayed for luciferase activity by mixing 10 ml of cell
lysate with 30 ml of luciferase assay substrate (Promega)
and by measuring the emitted light in relative light units
(RLU) using a Lumat LB 9507 luminometer (Berthold
Technologies).
The samples’ total protein concentration was assayed
for the determination of relative light units per milligram
of protein. The protein content of each sample was
measured by using a BCA assay (Pierce, Rockford, IL)
following the manufacturer’s recommended protocol.
Absorbance was recorded at 630 nm using a Dynatech
MR5000 plate reader and a standard curve was produced
using serial dilutions of bovine serum albumin protein
(02 mg/ml) to determine the protein content of each
sample.
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